Literature DB >> 6667034

The relationship of hyperactivity to moderately elevated lead levels.

O J David, S P Hoffman, J Clark, G Grad, J Sverd.   

Abstract

Controversy exists with respect to whether moderately elevated lead levels are toxic in certain children with various central nervous system dysfunctions. One way of addressing this controversy is to remove the lead; if the condition is ameliorated a presumption of toxicity becomes reasonable. Such a strategy is reported herein. Children with an operationally defined central nervous system dysfunction (hyperactivity) and moderately elevated lead levels were treated with a lead chelating agent in a random allocation double blind treatment regimen. The finding of statistically significant and obvious behavioral improvement reported by three separate evaluators (i.e., parent, teacher, and treating physician) of the child suggests that the presumption of a toxic relationship between moderately elevated lead levels and hyperactivity is supported.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6667034     DOI: 10.1080/00039896.1983.10545818

Source DB:  PubMed          Journal:  Arch Environ Health        ISSN: 0003-9896


  4 in total

1.  Children's classroom behavior and lead in Taiwan.

Authors:  M B Rabinowitz; J D Wang; W T Soong
Journal:  Bull Environ Contam Toxicol       Date:  1992-02       Impact factor: 2.151

2.  Long-term potentiation in the piriform cortex is blocked by lead.

Authors:  D O Carpenter; M R Matthews; P J Parsons; N Hori
Journal:  Cell Mol Neurobiol       Date:  1994-12       Impact factor: 5.046

3.  Lead reduces depolarization-induced calcium entry in cultured DRG neurons without crossing the cell membrane: fura-2 measurements.

Authors:  R Domann; L Wunder; D Büsselberg
Journal:  Cell Mol Neurobiol       Date:  1997-06       Impact factor: 5.046

4.  Lead exposure, IQ, and behavior in urban 5- to 7-year-olds: does lead affect behavior only by lowering IQ?

Authors:  Aimin Chen; Bo Cai; Kim N Dietrich; Jerilynn Radcliffe; Walter J Rogan
Journal:  Pediatrics       Date:  2007-03       Impact factor: 7.124

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.